Home

Nadja West

CIK 1787802 · last filed 2026-09-01

Nadja West is a corporate insider who has filed 39 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing shows the insider sold $207.0K of TEM on Sep 1, 2026. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.4M across reported positions. 10 SEC filings were submitted jointly with Tempus AI, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.41M

Companies

5

Total Filings

39

Lifetime Open-Market Net

-$1.95M

Filer Profile

Reported Address
C/O JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933
Related Filers
Tempus AI, Inc. — 10 joint filings, latest 2026-09-01
& JOHNSON JOHNSON — 7 joint filings, latest 2026-04-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TEM Director 31,981 $64.66 $2.07M -$783.0K 7 2026-09-01
NUE Director 10,703 $262.47 $2.81M $0 7 2026-06-03
THC Director 24,805 $263.49 $6.54M -$1.17M 14 2026-05-28
JOHNSON & JOHNSON (JNJ.WD) Delisted Director — — — $0 3 2026-04-27
JNJ Director — $278.43 — $0 3 2023-05-02

Recent Filings

39 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-01 TEM Sell (S) −3,000 -$207.0K EDGAR
2026-08-18 TEM Sell (S) −3,000 -$161.7K EDGAR
2026-08-14 TEM Notice (144) −6,000 -$325.7K EDGAR
2026-06-03 NUE Grant (A) +755 $0 EDGAR
2026-05-28 THC Mixed −3,000 -$532.0K EDGAR
2026-05-27 THC Notice (144) −3,000 -$532.0K EDGAR
2026-05-26 TEM Grant (A) +5,913 $0 EDGAR
2026-05-26 THC Mixed +840 -$85.7K EDGAR
2026-04-27 JOHNSON & JOHNSON (JNJ.WD) Delisted Grant (A) — $0 EDGAR
2026-02-18 THC Gift (G) −1,515 $0 EDGAR
Showing 1–10 of 39
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.